ADMA Biologics
ADMA
ADMA
58 hedge funds and large institutions have $165M invested in ADMA Biologics in 2018 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 23 increasing their positions, 12 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
5% more funds holding
Funds holding: 55 → 58 (+3)
2.41% more ownership
Funds ownership: 55.09% → 57.5% (+2.4%)
Holders
58
Holding in Top 10
3
Calls
$5K
Puts
–
Top Buyers
| 1 | +$7.54M | |
| 2 | +$1.8M | |
| 3 | +$1.53M | |
| 4 |
Renaissance Technologies
New York
|
+$988K |
| 5 |
JP Morgan Chase
New York
|
+$503K |
Top Sellers
| 1 | -$3.75M | |
| 2 | -$1.03M | |
| 3 | -$497K | |
| 4 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
-$242K |
| 5 |
SIM
Spark Investment Management
New York
|
-$168K |